Latest / The National Briefing
A Pretoria High Court ruling has temporarily halted the manufacture and sale of compounded semaglutide products by a local pharmacy group, following legal action by pharmaceutical giant Novo Nordisk.
A Pretoria High Court ruling has temporarily halted the manufacture and sale of compounded semaglutide products by a local pharmacy group, following legal action by pharmaceutical giant Novo Nordisk. The court found that the products, marketed as weight-loss treatments similar to Ozempic and Wegovy, had not been approved by South African regulators and raised concerns about quality, safety and compliance.
Guest: Elske Rich, Registered Dietitian and spokesperson for the Association for Dietetics in South Africa (ADSA).
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.